Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?
- PMID: 36985286
- PMCID: PMC10051562
- DOI: 10.3390/microorganisms11030713
Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?
Abstract
The relationship between viral infections and the risk of developing cancer is well known. Multiple mechanisms participate in and determine this process. The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in the deaths of millions of people worldwide. Although the effects of COVID-19 are limited for most people, a large number of people continue to show symptoms for a long period of time (long COVID). Several studies have suggested that cancer could also be a potential long-term complication of the virus; however, the causes of this risk are not yet well understood. In this review, we investigated arguments that could support or reject this possibility.
Keywords: COVID-19; SARS-CoV-2; cancer; immunosuppression; inflammation; senescence.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1. Arch Razi Inst. 2021. PMID: 33818952 Free PMC article.
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5. Trials. 2021. PMID: 33430924 Free PMC article.
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2020 Nov 20;11(11):CD006207. doi: 10.1002/14651858.CD006207.pub5. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2023 Jan 30;1:CD006207. doi: 10.1002/14651858.CD006207.pub6. PMID: 33215698 Free PMC article. Updated.
-
Collateral impact of COVID-19: why should children continue to suffer?Eur J Pediatr. 2021 Jun;180(6):1975-1979. doi: 10.1007/s00431-021-03963-x. Epub 2021 Feb 13. Eur J Pediatr. 2021. PMID: 33580826 Free PMC article. Review.
Cited by
-
Wuhan strain of SARS-CoV-2 triggers activation of immune evasion machinery similar to the one operated by cancer cells.Front Immunol. 2025 Jun 18;16:1599352. doi: 10.3389/fimmu.2025.1599352. eCollection 2025. Front Immunol. 2025. PMID: 40607414 Free PMC article.
-
Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies.Molecules. 2024 Nov 25;29(23):5564. doi: 10.3390/molecules29235564. Molecules. 2024. PMID: 39683724 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous